Related Experiment Video
Updated: Sep 22, 2025
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Inflammatory bowel disease biomarkers
Dandan Liu1, Varma Saikam1, Katie A Skrada1
1Department of Chemistry, 788 Petit Science Center, Georgia State University, Atlanta, Georgia, USA.
New noninvasive biomarkers, including serological markers and microRNAs, show promise for managing inflammatory bowel disease (IBD). These advancements could reduce patient discomfort and improve IBD prognosis and treatment.
Area of Science:
- Gastroenterology
- Biomarker Discovery
- Molecular Biology
Background:
- Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, involves chronic gastrointestinal inflammation.
- Current diagnostic and management methods like endoscopy and biopsy are invasive and costly.
- There is a need for less invasive and more accessible tools for IBD prognosis and monitoring.
Purpose of the Study:
- To review recent advancements in noninvasive biomarkers for inflammatory bowel disease (IBD).
- To highlight the potential of novel serological biomarkers and microRNAs in IBD management.
- To explore how these biomarkers can improve patient outcomes and reduce morbidity.
Main Methods:
- Literature review of recent studies on IBD biomarkers.
- Focus on serological biomarkers and microRNAs.
- Analysis of their potential clinical applications in IBD management.
Main Results:
- Emerging serological biomarkers show potential for IBD detection and monitoring.
- MicroRNAs are identified as promising noninvasive indicators for IBD.
- These novel biomarkers offer an alternative to invasive diagnostic procedures.
Conclusions:
- Novel serological biomarkers and microRNAs represent a significant advancement in IBD management.
- These noninvasive tools could lead to improved patient comfort and reduced healthcare costs.
- Further research is warranted to validate these biomarkers for routine clinical use in IBD.
More Related Videos
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...